Matthew Ackers-Johnson

Matthew Ackers-Johnson

Auto-generated profile, based on publicly available information

Matthew Ackers-Johnson

Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in Circulation
Verified
Journal Article
Open access
PDF file
MCMark Y Chan
Mark Y Chan
MEMotakis Efthymios
Motakis Efthymios
STSock Hwee Tan
Sock Hwee Tan
JPJohn W. Pickering
John W. Pickering
RTRichard Troughton
Richard Troughton
ARA. Mark Richards
A. Mark Richards
Background: Heart failure (HF) is the most common long-term complication of acute myocardial infarction (MI). Understanding plasma proteins associated with post-MI HF and their gene expression may identify new candidates for biomarker and drug target discovery. Methods: We employed aptamer-based affinity-capture plasma proteomics to measure 1305 plasma proteins at one month post-MI in a New Zealand cohort (CDCS) including 181 post-MI patients who were subsequently hospitalized for HF compared with 250 post-MI patients who remained event-free over a median follow-up of 4.9 years. We then correlated plasma proteins with left ventricular ejection fraction measured at 4 months post-MI and identified proteins potentially co-regulated in post-MI HF using Weighted Gene Co-expression Network Analysis (WCGNA). A Singapore cohort (IMMACULATE) of 223 post-MI patients, of which 33 patients were hospitalized for HF (median follow-up 2.0 years), was used for further candidate enrichment of plasma proteins using Fisher meta-analysis, resampling-based statistical testing and machine learning. We then cross-referenced differentially-expressed proteins with their differentially-expressed genes from single-cell transcriptomes of non-myocyte cardiac cells isolated from a murine MI model, and single-cell and single-nuclei transcriptomes of cardiac myocytes from murine HF models and human HF patients. Results: In the CDCS cohort, 212 differentially-expressed plasma proteins were significantly associated with subsequent HF events. Of these, 96 correlated with left ventricular ejection fraction measured at 4 months post-MI. WCGNA prioritised 63 of the 212 proteins that demonstrated significantly higher correlations among patients who developed post-MI HF compared with event-free controls (dataset 1). Cross-cohort meta-analysis of the IMMACULATE cohort identified 36 plasma proteins associated with post-MI HF (dataset 2) while single-cell transcriptomes identified 15 gene-protein candidates (dataset 3). The majority of prioritized proteins were of matricellular origin. The 6 most highly-enriched proteins that were common to all 3 datasets included well-established biomarkers of post-MI HF - N-terminal B-type natriuretic peptide and troponin T - as well as newly-emergent biomarkers - angiopoietin-2, thrombospondin-2, latent transforming growth factor-β binding protein-4 and follistatin-related protein-3. Conclusions: Large-scale human plasma proteomics, cross-referenced to unbiased cardiac cell transcriptomics at single-cell resolution, prioritized protein candidates associated with post-MI HF for further mechanistic and clinical validation.

12 June 2025 in Nature Materials
Verified
Journal Article
Open access
PDF file
ASAvery Rui Sun
Avery Rui Sun
FRFaris H. Ramli
Faris H. Ramli
XSXingyu Shen
Xingyu Shen
KRKarthikbabu Kannivadi Ramakanth
Karthikbabu Kannivadi Ramakanth
DCDixiao Chen
Dixiao Chen
JYJennifer L. Young
Jennifer L. Young
Extracellular matrix remodelling of cardiac tissue is a key contributor to age-related cardiovascular disease and dysfunction. Such remodelling is multifaceted including changes to the biochemical composition, architecture and mechanics, clouding our understanding of how and which extracellular matrix properties contribute to a dysfunctional state. Here we describe a decellularized extracellular matrix–synthetic hydrogel hybrid scaffold that independently confers two distinct matrix properties—ligand presentation and stiffness—to cultured cells in vitro, allowing for the identification of their specific roles in cardiac ageing. The hybrid scaffold maintains native matrix composition and organization of young or aged murine cardiac tissue, whereas its mechanical properties can be independently tuned to mimic young or aged tissue stiffness. Seeding these scaffolds with murine primary cardiac fibroblasts, we identify distinct age- and matrix-dependent mechanisms of cardiac fibroblast activation, matrix remodelling and senescence. Importantly, we show that the ligand presentation of a young extracellular matrix can outweigh the profibrotic stiffness cues typically present in an aged extracellular matrix in maintaining or driving cardiac fibroblast quiescence. Ultimately, these tunable scaffolds can enable the discovery of specific extracellular targets to prevent ageing dysfunction and promote rejuvenation.

4 June 2024 in Circulation
Verified
Journal Article
Closed access
YZYike Zhu
Yike Zhu
MAMatthew Ackers-Johnson
Matthew Ackers-Johnson
MSMuthu K. Shanmugam
Muthu K. Shanmugam
LEROY SIVAPPIRAGASAM PAKKIRILEROY SIVAPPIRAGASAM PAKKIRI
LEROY SIVAPPIRAGASAM PAKKIRI
Chester Lee DrumChester Lee Drum
Chester Lee Drum
RFRoger S.Y. Foo
Roger S.Y. Foo
BACKGROUND: Adult mammalian cardiomyocytes have limited proliferative capacity, but in specifically induced contexts they traverse through cell-cycle reentry, offering the potential for heart regeneration. Endogenous cardiomyocyte proliferation is preceded by cardiomyocyte dedifferentiation (CMDD), wherein adult cardiomyocytes revert to a less matured state that is distinct from the classical myocardial fetal stress gene response associated with heart failure. However, very little is known about CMDD as a defined cardiomyocyte cell state in transition. METHODS: Here, we leveraged 2 models of in vitro cultured adult mouse cardiomyocytes and in vivo adeno-associated virus serotype 9 cardiomyocyte–targeted delivery of reprogramming factors ( Oct4 , Sox2 , Klf4 , and Myc ) in adult mice to study CMDD. We profiled their transcriptomes using RNA sequencing, in combination with multiple published data sets, with the aim of identifying a common denominator for tracking CMDD. RESULTS: RNA sequencing and integrated analysis identified Asparagine Synthetase ( Asns ) as a unique molecular marker gene well correlated with CMDD, required for increased asparagine and also for distinct fluxes in other amino acids. Although Asns overexpression in Oct4 , Sox2 , Klf4 , and Myc cardiomyocytes augmented hallmarks of CMDD, Asns deficiency led to defective regeneration in the neonatal mouse myocardial infarction model, increased cell death of cultured adult cardiomyocytes, and reduced cell cycle in Oct4 , Sox2 , Klf4 , and Myc cardiomyocytes, at least in part through disrupting the mammalian target of rapamycin complex 1 pathway. CONCLUSIONS: We discovered a novel gene Asns as both a molecular marker and an essential mediator, marking a distinct threshold that appears in common for at least 4 models of CMDD, and revealing an Asns /mammalian target of rapamycin complex 1 axis dependency for dedifferentiating cardiomyocytes. Further study will be needed to extrapolate and assess its relevance to other cell state transitions as well as in heart regeneration.

13 May 2025 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
NSNilanjana Sadhu
Nilanjana Sadhu
RDRinkoo Dalan
Rinkoo Dalan
PJPritesh R. Jain
Pritesh R. Jain
CLChang Jie Mick Lee
Chang Jie Mick Lee
LPLeroy Sivappiragasam Pakkiri
Leroy Sivappiragasam Pakkiri
JCJohn C. Chambers
John C. Chambers

9 January 2026 in Science Advances
Verified
Journal Article
Open access
JYJing Yu
Jing Yu
ZJZhi Jiang
Zhi Jiang
MAMatthew Ackers-Johnson
Matthew Ackers-Johnson
GZGuijin Zou
Guijin Zou
Feilong ZhangFeilong Zhang
Feilong Zhang
XCXiaodong Chen
Xiaodong Chen
Existing bioelectronics often exhibit megapascal-scale moduli, despite the mechanosensitive nature of cardiomyocytes. Bridging the mechanical mismatch between tissue and bioelectronics is indispensable for building physiologically relevant in vitro cardiac models and advancing therapies. Here, we present Pliable Ultrathin Layered Sensing Electronics (PULSE), a platform with tissue-matched modulus (~10 kilopascals) and stretchable gold microcircuitry for long-term, high-fidelity monitoring of cardiac electrophysiology in vitro. Composed of a soft gel matrix and an ultrathin nanofilm embedded with gold circuits, our device achieves unprecedented tissue integration and preserves natural cardiomyocyte mechanics, resulting in a 140% increase in mechanical contraction and a 100% increase in electrical signals compared to conventional electronics. Cardiac tissue that grows our device exhibited enhanced drug sensitivity and response in cardiac dysfunction, revolutionizing disease modeling. By facilitating seamless interaction at the tissue-electronic interface, our platform offers a transformative perspective for advancing cardiac modeling and next-generation bioelectronic applications.

6 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SPStyliana Philippou
Styliana Philippou
NMNikolaos P. Mastroyiannopoulos
Nikolaos P. Mastroyiannopoulos
MTMarios Tomazou
Marios Tomazou
AOAnastasis Oulas
Anastasis Oulas
MAMatthew Ackers-Johnson
Matthew Ackers-Johnson
Leonidas A. PhylactouLeonidas A. Phylactou
Leonidas A. Phylactou
In vivo SELEX is an advanced adaptation of Systematic Evolution of Ligands by Exponential Enrichment (SELEX) that allows the development of aptamers capable of recognizing targets directly within their natural microenvironment. While this methodology ensures a higher translation potential for the selected aptamer, it does not select for aptamers that recognize specific cell types within a tissue. Such aptamers could potentially improve the development of drugs for several diseases, including neuromuscular disorders, by targeting solely the proteins involved in their pathogenesis. Here, we describe our attempt to utilize in vivo SELEX with a modification in the methodology that drives the selection of intravenously injected aptamers towards a specific cell type of interest. Our data suggest that the incorporation of a cell enrichment step can direct the in vivo localization of RNA aptamers into cardiomyocytes, the cardiac muscle cells, more readily over other cardiac cells. Given the crucial role of cardiomyocytes in the disease pathology in DMD cardiomyopathy and therapy, these aptamers hold great potential as drug delivery vehicles with cardiomyocyte selectivity.